Testing Ultraprocessed Food Labels in Chile
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 18, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how warning labels on ultraprocessed foods affect the choices that parents make when shopping for their children. Ultraprocessed foods are items that have been heavily processed and often contain unhealthy ingredients. The study will see if these warning labels make parents less likely to buy these foods, especially when they are also seeing other labels that warn about high levels of certain nutrients, like sodium and saturated fats. Participants will view three similar ultraprocessed products and share their thoughts on whether they would buy them and if they recognize them as ultraprocessed.
To be eligible for this study, you need to be at least 18 years old and a parent or guardian of a child aged 2 to 14 who has not been diagnosed with diabetes or related health issues. The trial is not yet recruiting participants, but once it begins, those who join will help researchers understand how effective these warning labels can be in helping families make healthier food choices.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • Parent or guardian of child between 2-14 years old who has never been diagnosed with diabetes, high blood sugar, pre-diabetes or insulin resistance
- • Residing in Chile
- Exclusion Criteria:
- • Less than 18 years old
- • Not parent or guardian of child between 2-14 years old who has never been diagnosed with diabetes, high blood sugar, pre-diabetes or insulin resistance
- • Not residing in Chile
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Aline D'Angelo Campos, MPP
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported